Currently we are associated with Multi National Company for its project (Phase III) in the field of Nephrology, Gynaecology and with another MNC for its post market surveillance in oncology specialty.

This shows clinical research/pharma industry's faith upon us for precise and reliable data.

E7080-M091-511 Tittle “ A Prospective, Multicentre, Post-Marketing Phase IV Study to Assess the safety and Efficacy of Lenvatinib as First-Line Treatment in Patients with Unresectable Hepatocellular Carcinoma (HCC)”.

Principle Investigator : Dr. Naresh Somani (Profile)

Co-Investigator : Dr. Rajesh Khurana (Profile)